Stem Cell Immunogenicity

Foreseeing the immunogenicity of a stem cell therapy is fundamental to empower sheltered and powerful procedures for anticipating invulnerable assault to be outlined. The immunogenicity of autologous prompted PSCs (iPSCs) changes between clones. Undifferentiated immature microorganisms are more immunogenic than their separated offspring. Distinctive kinds of tissue separated from a similar foundational microorganism can show diverse levels of immunogenicity. Stem cells jumbled with the patient for real histocompatibility complex (MHC) as well as minor histocompatibility (miH) antigens are immunogenic. miH antigen contrasts can be acquainted by the advancements utilized with creating pluripotent immature microorganisms (PSC, for example, confused mitochondrial antigens present in the enucleated oocytes used to deliver atomic exchange embryonic foundational microorganisms (NT-ESC).

 

  • Embryonic Stem Cells
  • Cell Therapy
  • Allogeneic Immune Rejection
  • Immune Tolerance
  • Pluripotent Stem Cells
  • Stem Cell Transplantation
  • ELISPOT
  • Major Histocompatibility Complex

Related Conference of Stem Cell Immunogenicity

June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 14-15, 2019

Annual Congress on Antibiotics and Antimicrobial Resistance

Geneva, Switzerland
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE
November 25-26 , 2019

Global meet on Immunology and Molecular Biology

Paris, France
November 28-29, 2019

International Conference on Vaccines and Immune Response

Helsinki, Finland

Stem Cell Immunogenicity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in